Primary Care

Two randomized, placebo-controlled studies evaluated treatment across the full spectrum of narcolepsy type 1 symptoms in adults.

Prediction models identified factors associated with concomitant and future psoriatic arthritis among patients with new-onset psoriasis.

The FDA approved the first-in-class targeted therapy based on a clinical trial evaluating overall survival among adults with previously treated metastatic pancreatic adenocarcinoma.

A US cohort study estimated chronic traumatic encephalopathy prevalence at death among former NFL players and its association with dementia.

At the August 2026 Practical Updates in Primary Care Virtual Meeting, Rakesh Jain, MD, MPH, and Laura Melaro, DNP, APRN, FNP-BC, PMHNP-BC, outlined a practical primary care approach to adult...

A randomized crossover trial examined whether N-of-1 deprescribing trials could identify older men receiving little symptomatic benefit from chronic tamsulosin therapy.

Intismeran autogene plus pembrolizumab met the primary recurrence-free survival and a key secondary distant metastasis-free survival endpoint in the phase 3 INTerpath-001 trial in patients with completely...

In their Practical Updates in Primary Care session, Jeanne M. Ferrante, MD, MPH, and Nell Maloney Patel, MD, FACS, FASCRS, discussed evidence-based cancer screening updates for primary care, with emphasis...

In this video, Brittany Watson, MD, MPH, FAAFP, DABOM and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of primary care in the early recognition and diagnosis of multiple myeloma, including the...

The FDA approved an mRNA-based influenza vaccine mFLUSIVA for adults aged 50 years and older, with accelerated approval applying to adults aged 65 years and older.